Over The Counter (OTC) Drugs Global Market Report 2024

Description

Over-the-counter (OTC) drugs are medications that can be obtained without a prescription from a healthcare professional. These drugs are deemed safe and effective for use by the general public when adhering to the instructions provided on the label. Typically, OTC drugs target minor health conditions and symptoms such as headaches, colds, allergies, pain, and digestive issues.

The primary product categories of OTC drugs encompass cough, cold, and flu products, analgesics, dermatology products, gastrointestinal products, vitamins, minerals, and supplements (VMS), weight loss or dietary products, ophthalmic products, sleeping aids, and others. For instance, cough, cold, and flu products are formulated to alleviate symptoms associated with respiratory infections, including coughing, congestion, and fever, and are available in various formulations such as tablets, liquids, ointments, and sprays. OTC drugs are distributed through various channels, including hospital pharmacies, retail pharmacies, online pharmacies, and others, and are utilized by a diverse range of end-users, primarily specialty clinics, homecare, hospitals, among others.

The over the counter (OTC) drugs market research report is one of a series of new reports from The Business Research Company that provides over the counter (OTC) drugs market statistics, including over the counter (OTC) drugs industry global market size, regional shares, competitors with a over the counter (OTC) drugs market share, detailed over the counter (OTC) drugs market segments, market trends and opportunities, and any further data you may need to thrive in the over the counter (OTC) drugs industry. This over the counter (OTC) drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The over the counter (OTC) drugs market size has grown strongly in recent years. It will grow from $149.57 billion in 2023 to $158.26 billion in 2024 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to regulatory changes, consumer awareness, healthcare accessibility, demographic trends, and economic factors.

The over the counter (OTC) drugs market size is expected to see strong growth in the next few years. It will grow to $199.99 billion in 2028 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to increasing self-medication practices, expanding retail distribution channels, chronic disease burden, product innovation, and global health trends. Major trends in the forecast period include rising demand for natural and herbal remedies, expansion of e-commerce platforms, personalized medicine and targeted therapies, emphasis on preventive healthcare, and integration of digital health technologies.

The anticipated rise in lifestyle-related health issues is set to drive the expansion of the over-the-counter (OTC) drugs market in the future. These health issues, influenced by individual habits and choices in areas such as diet, exercise, substance use, and stress management, have become increasingly prevalent due to modern lifestyles. Sedentary habits, poor dietary choices, smoking, excessive alcohol consumption, and heightened stress levels contribute to this trend. OTC drugs offer a convenient and accessible means of managing common conditions associated with contemporary living, playing a significant role in addressing lifestyle-related health issues. For example, as of March 2022, the World Health Organization reported that globally, around 1 billion individuals were obese, with projections indicating a continued increase. By 2025, it is estimated that 167 million adults and children will suffer health consequences due to excess weight. Additionally, according to the International Diabetes Federation in 2021, the number of individuals living with diabetes is expected to rise to 643 million by 2030 and 783 million by 2045. These statistics underscore the growing importance of addressing lifestyle-related health concerns, thereby fueling the demand for OTC drugs.

Key players in the OTC drug market are leveraging innovation to gain a competitive edge, with a focus on developing novel products such as over-the-counter sprays. These sprays offer a user-friendly and effective way to administer therapeutic agents directly to targeted areas of the body. For instance, in August 2023, Emergent BioSolutions Inc., a US-based biotech company, introduced its over-the-counter NARCAN Naloxone HCl Nasal Spray 4 mg. This product provides a rapid means of reversing opioid effects, including those of potent synthetic opioids such as fentanyl, facilitating quick emergency response, even among individuals without medical training.

In September 2023, Cipla South Africa, a subsidiary of India-based Cipla Limited, acquired Actor Pharma (Pty) Ltd. for $49 million. This acquisition expanded Cipla's portfolio of consumer brands and enhanced its presence in the South African OTC pharmaceutical market. Actor Pharma specializes in generic and OTC medicines, aligning with Cipla's goal of catering to diverse healthcare needs and strengthening its position in key markets.

Major companies operating in the over the counter (OTC) drugs market are Pfizer Inc., Johnson & Johnson Private Limited, The Procter & Gamble Company, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Ltd., Novo Nordisk A/S, Reckitt Benckiser Group PLC, Viatris Inc., Teva Pharmaceutical Industries Ltd., DAIICHI SANKYO COMPANY LIMITED, Sun Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Perrigo Company plc, Cipla Inc., Dr. Reddy's Laboratories Ltd., Alkem Laboratories Limited, Piramal Enterprises Ltd.

North America was the largest region in the over the counter (OTC) drugs market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the over the counter (OTC) drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the over the counter (OTC) drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The over-the-counter (OTC) drugs market consists of sales of pain relievers, allergy medications, first aid supplies, anti-diarrheal medications, and nasal sprays. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Over The Counter (OTC) Drugs Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on over the counter (OTC) drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for over the counter (OTC) drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The over the counter (OTC) drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product Type: Cough, Cold And Flu Products; Analgesics; Dermatology Products; Gastrointestinal Products; Vitamins, Mineral And Supplements (VMS); Weight Loss Or Dietary Products; Ophthalmic Products; Sleeping Aids; Other Product Types
2) By Formulation Type: Tablets; Liquids; Ointments; Sprays
3) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Channels
4) By End-Users: Specialty Clinics; Homecare; Hospitals; Other End Users
Companies Mentioned: Pfizer Inc.; Johnson & Johnson Private Limited; The Procter & Gamble Company; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r18196

1. Executive Summary

2. Over The Counter (OTC) Drugs Market Characteristics

3. Over The Counter (OTC) Drugs Market Trends And Strategies

4. Over The Counter (OTC) Drugs Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Over The Counter (OTC) Drugs Market Size and Growth

5.1. Global Over The Counter (OTC) Drugs Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Over The Counter (OTC) Drugs Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Over The Counter (OTC) Drugs Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Over The Counter (OTC) Drugs Market Segmentation

6.1. Global Over The Counter (OTC) Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Cough, Cold And Flu Products
Analgesics
Dermatology Products
Gastrointestinal Products
Vitamins, Mineral And Supplements (VMS)
Weight Loss Or Dietary Products
Ophthalmic Products
Sleeping Aids
Other Product Types
6.2. Global Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Tablets
Liquids
Ointments
Sprays
6.3. Global Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Other Channels
6.4. Global Over The Counter (OTC) Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Specialty Clinics
Homecare
Hospitals
Other End Users

7. Over The Counter (OTC) Drugs Market Regional And Country Analysis

7.1. Global Over The Counter (OTC) Drugs Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Over The Counter (OTC) Drugs Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Over The Counter (OTC) Drugs Market

8.1. Asia-Pacific Over The Counter (OTC) Drugs Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Over The Counter (OTC) Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Over The Counter (OTC) Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Over The Counter (OTC) Drugs Market

9.1. China Over The Counter (OTC) Drugs Market Overview
9.2. China Over The Counter (OTC) Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Over The Counter (OTC) Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Over The Counter (OTC) Drugs Market

10.1. India Over The Counter (OTC) Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Over The Counter (OTC) Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Over The Counter (OTC) Drugs Market

11.1. Japan Over The Counter (OTC) Drugs Market Overview
11.2. Japan Over The Counter (OTC) Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Over The Counter (OTC) Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Over The Counter (OTC) Drugs Market

12.1. Australia Over The Counter (OTC) Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Over The Counter (OTC) Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Over The Counter (OTC) Drugs Market

13.1. Indonesia Over The Counter (OTC) Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Over The Counter (OTC) Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Over The Counter (OTC) Drugs Market

14.1. South Korea Over The Counter (OTC) Drugs Market Overview
14.2. South Korea Over The Counter (OTC) Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Over The Counter (OTC) Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Over The Counter (OTC) Drugs Market

15.1. Western Europe Over The Counter (OTC) Drugs Market Overview
15.2. Western Europe Over The Counter (OTC) Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Over The Counter (OTC) Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Over The Counter (OTC) Drugs Market

16.1. UK Over The Counter (OTC) Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Over The Counter (OTC) Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Over The Counter (OTC) Drugs Market

17.1. Germany Over The Counter (OTC) Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Over The Counter (OTC) Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Over The Counter (OTC) Drugs Market

18.1. France Over The Counter (OTC) Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Over The Counter (OTC) Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Over The Counter (OTC) Drugs Market

19.1. Italy Over The Counter (OTC) Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Over The Counter (OTC) Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Over The Counter (OTC) Drugs Market

20.1. Spain Over The Counter (OTC) Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Over The Counter (OTC) Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Over The Counter (OTC) Drugs Market

21.1. Eastern Europe Over The Counter (OTC) Drugs Market Overview
21.2. Eastern Europe Over The Counter (OTC) Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Over The Counter (OTC) Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Over The Counter (OTC) Drugs Market

22.1. Russia Over The Counter (OTC) Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Over The Counter (OTC) Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Over The Counter (OTC) Drugs Market

23.1. North America Over The Counter (OTC) Drugs Market Overview
23.2. North America Over The Counter (OTC) Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Over The Counter (OTC) Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Over The Counter (OTC) Drugs Market

24.1. USA Over The Counter (OTC) Drugs Market Overview
24.2. USA Over The Counter (OTC) Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Over The Counter (OTC) Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Over The Counter (OTC) Drugs Market

25.1. Canada Over The Counter (OTC) Drugs Market Overview
25.2. Canada Over The Counter (OTC) Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Over The Counter (OTC) Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Over The Counter (OTC) Drugs Market

26.1. South America Over The Counter (OTC) Drugs Market Overview
26.2. South America Over The Counter (OTC) Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Over The Counter (OTC) Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Over The Counter (OTC) Drugs Market

27.1. Brazil Over The Counter (OTC) Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Over The Counter (OTC) Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Over The Counter (OTC) Drugs Market

28.1. Middle East Over The Counter (OTC) Drugs Market Overview
28.2. Middle East Over The Counter (OTC) Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Over The Counter (OTC) Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Over The Counter (OTC) Drugs Market

29.1. Africa Over The Counter (OTC) Drugs Market Overview
29.2. Africa Over The Counter (OTC) Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Over The Counter (OTC) Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Over The Counter (OTC) Drugs Market Competitive Landscape And Company Profiles

30.1. Over The Counter (OTC) Drugs Market Competitive Landscape
30.2. Over The Counter (OTC) Drugs Market Company Profiles
- 30.2.1. Pfizer Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Johnson & Johnson Private Limited
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. The Procter & Gamble Company
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. F. Hoffmann-La Roche Ltd.
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Merck & Co. Inc.
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Over The Counter (OTC) Drugs Market Other Major And Innovative Companies

31.1. AbbVie Inc.
31.2. Bayer AG
31.3. Sanofi S.A.
31.4. Bristol Myers Squibb Company
31.5. AstraZeneca PLC
31.6. Novartis AG
31.7. GlaxoSmithKline PLC
31.8. Takeda Pharmaceutical Company Ltd.
31.9. Novo Nordisk A/S
31.10. Reckitt Benckiser Group PLC
31.11. Viatris Inc.
31.12. Teva Pharmaceutical Industries Ltd.
31.13. DAIICHI SANKYO COMPANY LIMITED
31.14. Sun Pharmaceutical Industries Ltd.
31.15. Boehringer Ingelheim International GmbH

32. Global Over The Counter (OTC) Drugs Market Competitive Benchmarking

33. Global Over The Counter (OTC) Drugs Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Over The Counter (OTC) Drugs Market

35. Over The Counter (OTC) Drugs Market Future Outlook and Potential Analysis

35.1 Over The Counter (OTC) Drugs Market In 2028 - Countries Offering Most New Opportunities
35.2 Over The Counter (OTC) Drugs Market In 2028 - Segments Offering Most New Opportunities
35.3 Over The Counter (OTC) Drugs Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer